Partner/Owner

Representative before the EPO

Employment test 51 - 200 employees
Company dna maiwald patentanwalts gmbh
operating since 1995
Headquarter in Munich and 4 offices
active in Legal Services and IP Consulting

We have observed 99 EP applications Martin Huenges has served for within the last five+ years. (We consider all applications which have an EP A1 or A2 publication dated after November 18, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP12701298

COMPOSITIONS COMPRISING CROSSLINKED CATION- BINDING POLYMERS AND A BASE, USES THEREOF

IPC classification:
A23L 1/00, A61K 9/16
Agent:
Martin Huenges, Maiwald Patentanwalts GmbH
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12701299

COMPOSITIONS COMPRISING CROSSLINKED CATION- BINDING POLYMERS AND CALCIUM AND/OR MAGNESIUM CATIONS, AND USES THEREOF

IPC classification:
A61K 9/16
Agent:
Martin Huenges, Maiwald Patentanwalts GmbH
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12789707

HIGH THROUGHPUT METHYLATION DETECTION METHOD

IPC classification:
C40B 50/06, C40B 40/08, C40B 20/04, C12Q 1/68, C12N 15/11
Agent:
Martin Huenges, Maiwald Patentanwalts GmbH
Status:
The patent has been granted
EP12833860

THERAPEUTICS USING ADIPOSE CELLS AND CELL SECRETIONS

IPC classification:
A61K 35/12, C12N 5/0775, C12N 5/077, C12N 1/04, A61P 37/00, A61P 29/00, A61P 25/02, A61P 19/02, A61P 17/00
Agent:
Martin Huenges, Maiwald Patentanwalts GmbH
Status:
EXAMINATION IN PROGRESS
EP11875013

APPLICATION OF ROSEBURIA IN TREATING AND PREVENTING OBESITY RELATED DISEASES

IPC classification:
A61K 35/74, C12R 1/01, A61P 3/10, A61P 3/04
Applicant:
BGI Shenzhen Co., Limited
Agent:
Martin Huenges, Maiwald Patentanwalts GmbH
Status:
EXAMINATION IN PROGRESS
EP12791213

ISOTOPIC LABELING OF HIGHER ORGANISMS

IPC classification:
G01N 33/68, C12N 5/00
Applicant:
Silantes GmbH
Agent:
Martin Huenges, Maiwald Patentanwalts GmbH
Status:
EXAMINATION IN PROGRESS
EP12757105

PHARMACEUTICAL COMPOSITIONS AND TOPICAL USE THEREOF

IPC classification:
A61K 35/28, A61K 35/12, A61Q 7/00, A61P 17/14, A61P 17/12, A61P 17/10, A61P 17/02, A61P 17/00
Agent:
Martin Huenges, Maiwald Patentanwalts GmbH
Status:
PATENT GRANTED
EP13702627

COG-BASED MECHANISM FOR GENERATING AN ORBITAL SHAKING MOTION

IPC classification:
B06B 1/16, B04B 1/02, B01F 11/00
Applicant:
Quantifoil Instruments Gmbh
Agent:
Martin Huenges, Maiwald Patentanwalts GmbH
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP13701672

MECHANISM FOR GENERATING AN ORBITAL MOTION OR A ROTATION MOTION BY INVERSING A DRIVE DIRECTION OF A DRIVE UNIT

IPC classification:
B06B 1/16, B04B 1/02, B01F 11/00
Applicant:
Quantifoil Instruments Gmbh
Agent:
Martin Huenges, Maiwald Patentanwalts GmbH
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11848024

STEROID TETROL SOLID STATE FORMS-2

IPC classification:
A61K 31/568, C07J 1/00
Agent:
Martin Huenges, Maiwald Patentanwalts GmbH
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12865785

METHOD AND SYSTEM FOR DETERMINING WHETHER COPY NUMBER VARIATION EXISTS IN SAMPLE GENOME, AND COMPUTER READABLE MEDIUM

IPC classification:
G06F 19/00, C12Q 1/68, C12N 15/10
Applicant:
BGI Diagnosis Co., Ltd.
Agent:
Martin Huenges, Maiwald Patentanwalts GmbH
Status:
EXAMINATION IN PROGRESS
EP13725328

TRI-SUBSTITUTED GLYCEROL COMPOUNDS FOR USE IN THE TREATMENT OF CLINICALLY ISOLATED SYNDROME AND/OR MULTIPLE SCLEROSIS

IPC classification:
A61K 31/685, A61K 31/10, A61K 31/047, A61P 25/00
Agent:
Martin Huenges, Maiwald Patentanwalts GmbH
Status:
EXAMINATION IN PROGRESS
EP13729363

V1B RECEPTOR ANTAGONIST FOR USE IN THE TREATMENT OF PATIENTS HAVING AN ELEVATED AVP LEVEL AND/OR AN ELEVATED COPEPTIN LEVEL

IPC classification:
A61K 45/00, A61K 31/404, G01N 33/68, C07K 14/575
Applicant:
B.R.A.H.M.S GmbH
Agent:
Hertin und Partner Rechts- und Patentanwälte PartG mbB
Agent:
Martin Huenges, Maiwald Patentanwalts GmbH
Status:
The application has been published
EP13817599

RISK STRATIFICATION IN INFLUENZA

IPC classification:
G01N 33/53, C12Q 1/70, C12Q 1/68
Agent:
Martin Huenges, Maiwald Patentanwalts GmbH
Status:
GRANT OF PATENT INTENDED
EP13748253

METHODS OF PRODUCING SWEET JUICE COMPOSITIONS

IPC classification:
A23L 1/236, A23L 1/015
Applicant:
Guilin GFS Monk Fruit Corporation
Agent:
Martin Huenges, Maiwald Patentanwalts GmbH
Status:
PATENT GRANTED
EP13831228

POLYMERIC AND SOLID-SUPPORTED CATALYSTS, AND METHODS OF DIGESTING CELLULOSIC MATERIALS USING SUCH CATALYSTS

IPC classification:
B01J 31/08, B01J 21/10, B01J 21/08
Agent:
Martin Huenges, Maiwald Patentanwalts GmbH
Status:
GRANT OF PATENT INTENDED
EP13830609

POLYMERIC AND SOLID-SUPPORTED CATALYSTS, AND METHODS OF DIGESTING LIGNIN-CONTAINING MATERIALS USING SUCH CATALYSTS

IPC classification:
B01J 37/04, B01J 31/06
Agent:
Martin Huenges, Maiwald Patentanwalts GmbH
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13836701

COMPOSITIONS TARGETING BRADYKININ RECEPTOR B1 FOR MEDICAL IMAGING OF CANCER AND OTHER DISORDERS

IPC classification:
A61K 51/04, A61P 35/00
Agent:
Martin Huenges, Maiwald Patentanwalts GmbH
Status:
GRANT OF PATENT INTENDED
EP13840667

THERAPEUTICS USING MULTIPLE INJECTIONS OF CELLS

IPC classification:
C12N 5/07, A61P 19/02
Agent:
Martin Huenges, Maiwald Patentanwalts GmbH
Status:
GRANT OF PATENT INTENDED
EP14199188

Fused heteroaromatic pyrrolidinones as syk inhibitors

IPC classification:
A61K 31/519, A61K 31/437, C07D 487/04, C07D 471/04, A61P 37/00, A61P 35/00, A61P 29/00, A61P 19/00, A61P 17/00, A61P 11/00, A61P 7/00
Applicant:
Takeda Pharmaceutical Company Limited
Agent:
Martin Huenges, Maiwald Patentanwalts GmbH
Agent:
D Young & Co LLP
Status:
EXAMINATION IN PROGRESS
EP13795450

NUCLEIC ACID ASSAY FOR DIAGNOSING OR MONITORING A PATHOGEN INFECTION IN A BODILY FLUID FROM A SUBJECT TREATED WITH AN ANTI-PATHOGENIC AGENT

IPC classification:
C12Q 1/68
Applicant:
Alere Technologies GmbH
Agent:
Martin Huenges, Maiwald Patentanwalts GmbH
Status:
The patent has been granted
EP13862640

METHODS FOR DIAGNOSING AND TREATING PROSTATE CANCER

IPC classification:
G01N 33/574
Applicant:
Cornell University
Agent:
Martin Huenges, Maiwald Patentanwalts GmbH
Status:
The patent has been granted
EP13867300

VACCINES FOR THE TREATMENT OF CANCER AND COMPOSITIONS FOR ENHANCING VACCINE EFFICACY

IPC classification:
A61K 39/00, A61K 38/00, C12N 5/0775, C12N 5/077, A61P 35/00
Agent:
Martin Huenges, Maiwald Patentanwalts GmbH
Status:
GRANT OF PATENT INTENDED
EP13874559

PREPARING TOOTH-LIKE STRUCTURE USING STEM CELL

IPC classification:
A61P 1/02, A61K 6/00, C07K 14/51, C12N 5/0797, C12N 5/0789, C12N 5/0775, C12N 5/074, C12N 5/0735
Agent:
Martin Huenges, Maiwald Patentanwalts GmbH
Status:
EXAMINATION REQUESTED
EP14757595

METHOD FOR PRODUCING SULFONYL CHLORIDE COMPOUND

IPC classification:
C07D 401/12, C07D 213/71
Applicant:
Takeda Pharmaceutical Company Limited
Agent:
Martin Huenges, Maiwald Patentanwalts GmbH
Status:
EXAMINATION REQUESTED
EP13722922

METHODS OF PRODUCING ENRICHED POPULATIONS OF TUMOR-REACTIVE T CELLS FROM TUMOR

IPC classification:
C12N 5/0783, A61K 35/14
Applicant:
The United States of America as Represented by the Secretary, Department of Health and Human Services
Agent:
Martin Huenges, Maiwald Patentanwalts GmbH
Status:
EXAMINATION IN PROGRESS
EP13725231

METHODS OF PRODUCING ENRICHED POPULATIONS OF TUMOR REACTIVE T CELLS FROM PERIPHERAL BLOOD

IPC classification:
G01N 33/569, G01N 33/50, C12N 5/0783, A61K 35/14
Applicant:
The United States of America as Represented by the Secretary, Department of Health and Human Services
Agent:
Martin Huenges, Maiwald Patentanwalts GmbH
Status:
EXAMINATION IN PROGRESS
EP15166799

METHODS AND MATERIALS FOR TARGETED MUTAGENESIS

IPC classification:
C12N 15/10
Agent:
Martin Huenges, Maiwald Patentanwalts GmbH
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14716610

PLASMID FOR MINICIRCLE PRODUCTION

IPC classification:
C12N 15/79, C12N 15/64, C12N 15/00
Agent:
Martin Huenges, Maiwald Patentanwalts GmbH
Status:
The patent has been granted
EP14734461

APPLICATION-SPECIFIC SAMPLE PROCESSING BY MODULES SURROUNDING A ROTOR MECHANISM FOR SAMPLE MIXING AND SAMPLE SEPARATION

IPC classification:
G01N 35/00, B04B 5/10
Applicant:
Quantifoil Instruments Gmbh
Agent:
Martin Huenges, Maiwald Patentanwalts GmbH
Status:
EXAMINATION IN PROGRESS
EP14818491

PRODUCTION METHOD FOR POLYAMINO ACID

IPC classification:
C08G 69/10, A61K 39/39, C08G 69/48
Applicant:
Takeda Pharmaceutical Company Limited
Agent:
Martin Huenges, Maiwald Patentanwalts GmbH
Status:
GRANT OF PATENT INTENDED
EP14745056

METHODS OF PREPARING ANTI-HUMAN PAPILLOMAVIRUS ANTIGEN T CELLS

IPC classification:
A61K 35/14, C12N 5/0783
Agent:
Martin Huenges, Maiwald Patentanwalts GmbH
Status:
EXAMINATION IN PROGRESS
EP14748353

ANTI-HUMAN PAPILLOMAVIRUS 16 E6 T CELL RECEPTORS

IPC classification:
C07K 14/725
Agent:
Martin Huenges, Maiwald Patentanwalts GmbH
Status:
EXAMINATION IN PROGRESS
EP14834874

METHOD FOR PRODUCING DOPAMINERGIC NEURONS

IPC classification:
A61P 25/16, A61L 27/00, A61K 35/12, C12N 5/0793
Agent:
Martin Huenges, Maiwald Patentanwalts GmbH
Status:
GRANT OF PATENT INTENDED
EP14834225

AROMATIC COMPOUND

IPC classification:
C12N 15/09, C07D 413/14, C07D 413/10, C07D 409/12, C07D 405/14, C07D 405/12, C07D 401/14, C07D 401/12, C07D 401/10, A61P 43/00, A61P 3/10, A61K 31/5377, A61K 31/506, A61K 31/497, A61K 31/4545, A61K 31/454, A61K 31/4535, A61K 31/453, A61K 31/451, C07D 211/22
Applicant:
Takeda Pharmaceutical Company Limited
Agent:
Martin Huenges, Maiwald Patentanwalts GmbH
Status:
The patent has been granted
EP14851360

BIOMARKERS FOR CELL THERAPY

IPC classification:
A61P 37/00, A61P 19/02, A61P 1/00, A61K 35/12, G01N 33/68
Agent:
Martin Huenges, Maiwald Patentanwalts GmbH
Status:
GRANT OF PATENT INTENDED
EP14856224

HETEROCYCLIC COMPOUND

IPC classification:
C07D 277/20, C07D 241/26, C07D 241/24, C07D 239/56, C07D 239/54, C07D 239/48, C07D 239/47, C07D 239/42, C07D 239/36, A61P 43/00, A61P 25/28, A61P 25/18, A61K 31/55, A61K 31/5386, A61K 31/5377, A61K 31/506, A61K 31/505, A61K 31/497, A61K 31/4965, A61K 31/426, C07D 239/28
Applicant:
Takeda Pharmaceutical Company Limited
Agent:
Martin Huenges, Maiwald Patentanwalts GmbH
Status:
EXAMINATION REQUESTED
EP14803288

METHOD FOR SUBTYPING LYMPHOMA TYPES BY MEANS OF EXPRESSION PROFILING

IPC classification:
C12Q 1/68
Applicant:
Oregon Health & Science University
Applicant:
University of Arizona
Applicant:
Universitat de Barcelona - Centre de Patentes
Applicant:
Julius-Maximilians-University of Wuerzburg (Universität Würzburg)
Applicant:
Hospital Clínic de Barcelona
Applicant:
University of Nebraska
Agent:
Martin Huenges, Maiwald Patentanwalts GmbH
Status:
EXAMINATION REQUESTED
EP14802259

THYMIC STROMAL LYMPHOPOIETIN RECEPTOR-SPECIFIC CHIMERIC ANTIGEN RECEPTORS AND METHODS USING SAME

IPC classification:
C07K 16/46, C07K 16/30, C07K 14/725
Applicant:
The United States of America as Represented by the Secretary, Department of Health and Human Services
Agent:
Martin Huenges, Maiwald Patentanwalts GmbH
Status:
EXAMINATION REQUESTED
EP14870738

MICRONEEDLE

IPC classification:
A61K 47/36, A61K 47/26, A61K 47/24, A61K 47/10, A61K 39/145, A61K 39/12, A61K 39/00, A61K 9/00
Applicant:
Takeda Pharmaceutical Company Limited
Agent:
Martin Huenges, Maiwald Patentanwalts GmbH
Status:
EXAMINATION REQUESTED
EP14870867

WNT PATHWAY MODULATORS

IPC classification:
A61P 19/02, A61P 17/06, A61P 35/00, A61K 31/4162, C07D 487/04
Applicant:
Agency for Science, Technology and Research
Agent:
Martin Huenges, Maiwald Patentanwalts GmbH
Status:
The patent has been granted
EP14871224

MALEIMIDE DERIVATIVES AS MODULATORS OF WNT PATHWAY

IPC classification:
A61K 31/437, C07D 471/04
Applicant:
Agency for Science, Technology and Research
Agent:
Martin Huenges, Maiwald Patentanwalts GmbH
Status:
The patent has been granted
EP14833295

4-(PIPERRAZIN-1-YL)-PYRROLIDIN-2-ONE COMPOUNDS AS MONOACYLGLYCEROL LIPASE (MAGL) INHIBITORS

IPC classification:
A61P 25/00, A61K 31/496, C07D 417/14, C07D 417/12, C07D 413/12, C07D 405/12, C07D 403/04
Applicant:
Takeda Pharmaceutical Company Limited
Agent:
Martin Huenges, Maiwald Patentanwalts GmbH
Status:
EXAMINATION REQUESTED
EP15701450

ANTI-VIRAL CNIDARINS

IPC classification:
C07K 14/435, A61K 38/00
Applicant:
The United States of America as Represented by the Secretary, Department of Health and Human Services
Agent:
Martin Huenges, Maiwald Patentanwalts GmbH
Status:
EXAMINATION REQUESTED
EP15701442

ANTIBODY TARGETING CELL SURFACE DEPOSITED COMPLEMENT PROTEIN C3d AND USE THEREOF

IPC classification:
A61P 35/02, C07K 16/30, C07K 16/18
Applicant:
University of Virginia Patent Foundation
Agent:
Martin Huenges, Maiwald Patentanwalts GmbH
Status:
EXAMINATION IN PROGRESS
EP15704963

NUCLEOSOME SUBSTRATE ASSAYS

IPC classification:
G01N 33/68, G01N 33/58, G01N 33/573, G01N 33/542, C12N 15/10
Agent:
Martin Huenges, Maiwald Patentanwalts GmbH
Status:
EXAMINATION REQUESTED
EP15706080

ANTI-NY-BR-1 POLYPEPTIDES, PROTEINS, AND CHIMERIC ANTIGEN RECEPTORS

IPC classification:
C07K 16/30
Applicant:
The United States of America as Represented by the Secretary, Department of Health and Human Services
Agent:
Martin Huenges, Maiwald Patentanwalts GmbH
Status:
EXAMINATION REQUESTED
EP15707584

METHODS FOR DETECTING MULTIPLE NUCLEIC ACIDS IN A SAMPLE

IPC classification:
C12Q 1/68
Applicant:
Alere Technologies GmbH
Agent:
Martin Huenges, Maiwald Patentanwalts GmbH
Status:
EXAMINATION REQUESTED
EP15761818

PYRIDAZINE COMPOUND

IPC classification:
C07D 417/14, C07D 401/14, A61P 43/00, A61P 35/00, A61K 31/501, C07D 413/14
Applicant:
Takeda Pharmaceutical Company Limited
Agent:
Martin Huenges, Maiwald Patentanwalts GmbH
Status:
APPLICATION WITHDRAWN
EP15722809

HIGH ACTIVITY HYDROTREATING CATALYSTS

IPC classification:
C10G 45/08, B01J 31/04
Agent:
Martin Huenges, Maiwald Patentanwalts GmbH
Status:
EXAMINATION REQUESTED
EP16189800

METHODS OF PRODUCING SWEET JUICE COMPOSITIONS

IPC classification:
A23L 27/30, A23L 2/04, A23L 2/78
Applicant:
Guilin GFS Monk Fruit Corporation
Agent:
Martin Huenges, Maiwald Patentanwalts GmbH
Status:
Request for examination was made
EP15729304

CHIMERIC ANTIGEN RECEPTORS TARGETING CD-19

IPC classification:
C07K 16/28
Agent:
Martin Huenges, Maiwald Patentanwalts GmbH
Status:
EXAMINATION REQUESTED
EP15729004

ANTI-HUMAN PAPILLOMAVIRUS 16 E7 T CELL RECEPTORS

IPC classification:
A61K 38/17, C07K 14/725
Applicant:
The United States of America as Represented by the Secretary, Department of Health and Human Services
Agent:
Martin Huenges, Maiwald Patentanwalts GmbH
Status:
EXAMINATION REQUESTED
EP16198796

SMALL MOLECULE INHIBITORS OF TRPA1

IPC classification:
A61P 17/00, A61Q 19/00, A61K 8/36, A61K 31/192
Agent:
Martin Huenges, Maiwald Patentanwalts GmbH
Status:
Request for examination was made
EP16184030

PHARMACEUTICAL COMPOSITIONS AND TOPICAL USE THEREOF

IPC classification:
A61K 35/28, A61Q 7/00, A61P 17/14, A61P 17/12, A61P 17/10, A61P 17/02, A61P 17/00, A61K 35/12
Agent:
Martin Huenges, Maiwald Patentanwalts GmbH
Status:
Request for examination was made
EP16204878

DEVICE AND METHOD FOR DETECTING MOLECULAR INTERACTIONS

IPC classification:
B01L 7/00, G01N 21/64, C12Q 1/68, B01L 3/00, G01N 21/03
Applicant:
Alere Technologies GmbH
Agent:
Martin Huenges, Maiwald Patentanwalts GmbH
Status:
APPLICATION PUBLISHED
EP15824842

USE OF MULTIPLE TARGET NUCLEIC ACID DETECTION METHOD USING CLAMPING PROBE AND DETECTION PROBE

IPC classification:
C12Q 1/68
Agent:
Martin Huenges, Maiwald Patentanwalts GmbH
Status:
EXAMINATION REQUESTED
EP15838199

METHODS FOR TREATMENT AND PREVENTION OF VASCULAR DISEASE

IPC classification:
A61L 27/54, A61L 27/22, A61F 2/82, A61P 9/00, A61P 9/14, A61K 38/16
Agent:
Martin Huenges, Maiwald Patentanwalts GmbH
Status:
Request for examination was made
EP15840620

HETEROCYCLIC COMPOUND

IPC classification:
A61P 11/00, A61P 1/00, A61K 31/551, A61K 31/55, A61K 31/541, A61K 31/5377, A61K 31/517, C07D 239/96
Applicant:
Takeda Pharmaceutical Company Limited
Agent:
Martin Huenges, Maiwald Patentanwalts GmbH
Status:
Request for examination was made
EP15757074

LENTIVIRAL VECTOR FOR TREATING HEMOGLOBIN DISORDERS

IPC classification:
C12N 5/10, A61K 48/00, C12N 15/86
Agent:
Martin Huenges, Maiwald Patentanwalts GmbH
Status:
Request for examination was made
EP15788249

ADENOVIRAL VECTOR ENCODING HUMAN ATONAL HOMOLOG-1 (HATH1)

IPC classification:
A61K 48/00, C07K 14/47, C12N 15/861
Applicant:
GenVec Inc
Agent:
Martin Huenges, Maiwald Patentanwalts GmbH
Status:
Request for examination was made
EP14790878

METHODS OF ISOLATING T CELLS HAVING ANTIGENIC SPECIFICITY FOR A CANCER-SPECIFIC MUTATION

IPC classification:
A61P 35/00, C12N 5/0783
Agent:
Martin Huenges, Maiwald Patentanwalts GmbH
Status:
Request for examination was made
EP14796317

METHODS OF ISOLATING T CELL RECEPTORS HAVING ANTIGENIC SPECIFICITY FOR A CANCER-SPECIFIC MUTATION

IPC classification:
C12N 5/0783, C07K 14/47, C07K 14/725, A61K 39/00
Agent:
Martin Huenges, Maiwald Patentanwalts GmbH
Status:
Request for examination was made
EP15802225

METHODS FOR PRODUCING FUELS, GASOLINE ADDITIVES, AND LUBRICANTS USING AMINE CATALYSTS

IPC classification:
C10L 1/02, C07C 45/74, B01J 31/02
Applicant:
University of California
Applicant:
BP Corporation North America Inc.
Agent:
Martin Huenges, Maiwald Patentanwalts GmbH
Status:
Request for examination was made
EP15802226

METHODS FOR PRODUCING FUELS, GASOLINE ADDITIVES, AND LUBRICANTS USING AMINE CATALYSTS

IPC classification:
B01J 31/02, C10L 1/02, C07C 45/71
Applicant:
University of California
Applicant:
BP Corporation North America Inc.
Agent:
Martin Huenges, Maiwald Patentanwalts GmbH
Status:
Request for examination was made
EP15807756

ANTI-MUTATED KRAS T CELL RECEPTORS

IPC classification:
A61K 39/00, C07K 14/82, A61K 45/06
Applicant:
The United States of America as Represented by the Secretary, Department of Health and Human Services
Agent:
Martin Huenges, Maiwald Patentanwalts GmbH
Status:
Request for examination was made
EP15808247

ANTI-CARBAPENEMASE ANTIBODIES AND USES THEREOF

IPC classification:
C07K 16/12, G01N 33/573
Applicant:
Alere Technologies GmbH
Agent:
Martin Huenges, Maiwald Patentanwalts GmbH
Status:
Request for examination was made
EP15868687

IMPROVED CELL THERAPIES

IPC classification:
A61P 29/00, C12N 5/071, C12N 5/077, A61K 35/545
Agent:
Appleyard Lees Ltd
Agent:
Martin Huenges, Maiwald Patentanwalts GmbH
Status:
Request for examination was made
EP15718065

ANTI-CD70 CHIMERIC ANTIGEN RECEPTORS

IPC classification:
C07K 16/30, C07K 14/715, C07K 14/705, C07K 14/725
Agent:
Martin Huenges, Maiwald Patentanwalts GmbH
Status:
Request for examination was made
EP16702008

DETOXIFICATION AND STABILIZATION OF IMPLANTABLE OR TRANSPLANTABLE BIOLOGICAL MATERIAL

IPC classification:
A61L 27/36
Applicant:
University of the Free State
Agent:
Martin Huenges, Maiwald Patentanwalts GmbH
Status:
Request for examination was made
EP16747391

COMPOUNDS AND USES IN TREATMENT OF SENESCENCE-ASSOCIATED CONDITONS

IPC classification:
A61P 37/00, A61P 27/00, A61P 25/00, A61P 21/00, A61P 19/00, A61P 17/00, A61P 11/00, A61P 9/00, A61P 3/00, A61P 1/00, A61P 43/00, A61K 31/495
Agent:
Martin Huenges, Maiwald Patentanwalts GmbH
Status:
Request for examination was made
EP16710345

GRIFFITHSIN MUTANTS

IPC classification:
A61K 38/16, C07K 14/405
Applicant:
University of Pittsburgh of the Commonwealth System of Higher Education
Applicant:
University of Louisville Research Foundation, Inc.
Agent:
Martin Huenges, Maiwald Patentanwalts GmbH
Status:
Request for examination was made
EP16758925

PEPTIDE SYNTHESIS METHOD

IPC classification:
C07C 217/58, C07C 43/23, C07C 43/225, C07K 1/10
Agent:
Martin Huenges, Maiwald Patentanwalts GmbH
Status:
Request for examination was made
EP16762623

RP2 AND RPGR VECTORS FOR TREATING X-LINKED RETINITIS PIGMENTOSA

IPC classification:
A61K 48/00, A61P 27/02, C12N 7/01, C12N 15/864
Agent:
Martin Huenges, Maiwald Patentanwalts GmbH
Status:
Request for examination was made
EP16715122

FUSED BICYCLIC HETEROARYL DERIVATIVES HAVING ACTIVITY AS PHD INHIBITORS

IPC classification:
A61P 9/10, A61P 13/12, A61K 31/519, A61K 31/437, C07D 487/04, C07D 471/04
Applicant:
Takeda Pharmaceutical Company Limited
Agent:
Martin Huenges, Maiwald Patentanwalts GmbH
Status:
Request for examination was made
EP15823452

BISPECIFIC MULTIVALENT FUSION PROTEINS

IPC classification:
A61K 39/00, C07K 14/435, C07K 14/73, A61K 47/48, A61K 38/17, A61K 38/16, A61K 38/00, C07K 16/10
Applicant:
Fudan University
Agent:
Martin Huenges, Maiwald Patentanwalts GmbH
Status:
Request for examination was made
EP16772837

HETEROCYCLIC COMPOUND

IPC classification:
C12N 9/99, C07D 498/04, C07D 471/04, C07D 417/14, C07D 413/14, C07D 413/06, A61P 43/00, A61P 25/28, A61P 25/16, A61P 25/08, A61P 25/04, A61K 31/5383, A61K 31/538, A61K 31/4709, A61K 31/454, C07D 401/06
Applicant:
Takeda Pharmaceutical Company Limited
Agent:
Martin Huenges, Maiwald Patentanwalts GmbH
Status:
Request for examination was made
EP16771103

METHOD FOR PREDICTING RISK OF COGNITIVE DETERIORATION

IPC classification:
A61P 25/28, A61K 31/4412, A61B 5/055, G01N 29/04, G01N 24/08, G01N 33/68
Agent:
Martin Huenges, Maiwald Patentanwalts GmbH
Status:
Request for examination was made
EP16777501

GENE THERAPY TO PREVENT REACTIONS TO ALLERGENS

IPC classification:
C12N 15/00, A61K 39/395
Applicant:
Center for Technology Licensing (CTL) at Cornell University
Agent:
Martin Huenges, Maiwald Patentanwalts GmbH
Status:
Request for examination was made
EP16717228

VIRAL GENE THERAPY AS TREATMENT FOR CHOLESTEROL STORAGE DISEASE OR DISORDER

IPC classification:
C12N 15/864, A61P 25/28, A61K 48/00
Agent:
Martin Huenges, Maiwald Patentanwalts GmbH
Status:
Request for examination was made
EP16783269

HETEROCYCLIC COMPOUND

IPC classification:
C07D 417/14, C07D 413/04, A61P 43/00, A61P 25/30, A61P 25/28, A61P 25/24, A61P 25/22, A61P 25/20, A61P 25/18, A61K 31/553, C07D 413/14
Applicant:
Takeda Pharmaceutical Company Limited
Agent:
Martin Huenges, Maiwald Patentanwalts GmbH
Status:
Request for examination was made
EP16727258

AAV ISOLATE AND FUSION PROTEIN COMPRISING NERVE GROWTH FACTOR SIGNAL PEPTIDE AND PARATHYROID HORMONE

IPC classification:
C07K 14/635, C12N 15/86
Agent:
Martin Huenges, Maiwald Patentanwalts GmbH
Status:
Request for examination was made
EP15891099

REAGENT KIT, APPARATUS, AND METHOD FOR DETECTING CHROMOSOME ANEUPLOIDY

IPC classification:
C12Q 1/6869, G06F 19/18
Agent:
Martin Huenges, Maiwald Patentanwalts GmbH
Status:
Request for examination was made
EP17184354

MICROFLUIDIC DEVICE

IPC classification:
B01L 3/00, G01N 21/27, G01N 21/64
Applicant:
Alere Technologies GmbH
Agent:
Martin Huenges, Maiwald Patentanwalts GmbH
Status:
The application has been published
EP16800841

ADENO-ASSOCIATED VIRUS MEDIATED DELIVERY OF C1EI AS A THERAPY FOR ANGIOEDEMA

IPC classification:
C12N 15/861, A61K 39/395, A61K 39/00
Agent:
Martin Huenges, Maiwald Patentanwalts GmbH
Status:
Request for examination was made
EP16824803

MODULATION OF HEPATITIS B VIRUS REPLICATION

IPC classification:
A61P 31/20, A61K 38/04, A61K 38/00
Applicant:
Agency for Science, Technology and Research
Agent:
Martin Huenges, Maiwald Patentanwalts GmbH
Status:
Request for examination was made
EP16825278

SYNTHESES, ACTIVITIES, AND METHODS OF USE OF DIHYDRONICOTINAMIDE RIBOSIDE DERIVATIVES

IPC classification:
C07D 213/127, A61K 31/7105, A61K 31/44
Agent:
Martin Huenges, Maiwald Patentanwalts GmbH
Status:
Request for examination was made
EP16753995

1-SUBSTITUTED 1,2,3,4-TETRAHYDRO-1,7-NAPHTHYRIDIN-8-AMINE DERIVATIVES AND THEIR USE AS EP4 RECEPTOR ANTAGONISTS

IPC classification:
A61P 19/02, A61K 31/4375, A61K 31/542, A61K 31/4985, C07D 513/04, C07D 471/04, A61K 31/5383, C07D 498/04
Applicant:
Takeda Pharmaceutical Company Limited
Agent:
Martin Huenges, Maiwald Patentanwalts GmbH
Status:
Request for examination was made
EP17194540

ANGIOGENIC CONDITIONING TO ENHANCE CARDIAC CELLULAR REPROGRAMMING OF FIBROBLASTS OF THE INFARCTED MYOCARDIUM

IPC classification:
C07K 14/49, A61K 38/17, A61K 48/00, C07K 14/00, A61K 38/00, C07K 14/52, C12N 5/00, A01N 63/00
Applicant:
The State University of New York
Applicant:
Cornell University
Agent:
Martin Huenges, Maiwald Patentanwalts GmbH
Status:
The application has been published
EP16843295

CELL EXPANSION METHODS AND THERAPEUTIC COMPOSITIONS

IPC classification:
A61P 19/02, A61K 31/737, A61K 31/726, A61P 37/00, A61P 29/00, A61K 35/12, C12N 5/0775, C12N 5/02
Agent:
Martin Huenges, Maiwald Patentanwalts GmbH
Status:
Request for examination was made
EP16770410

ANTI-CD276 CHIMERIC ANTIGEN RECEPTORS

IPC classification:
C07K 14/725, C07K 14/705
Applicant:
The United States of America as Represented by the Secretary, Department of Health and Human Services
Agent:
Martin Huenges, Maiwald Patentanwalts GmbH
Status:
Request for examination was made
EP16770408

T CELL RECEPTORS RECOGNIZING HLA-CW8 RESTRICTED MUTATED KRAS

IPC classification:
A61K 38/00, A61K 45/06, C07K 14/82, C07K 14/725
Agent:
Martin Huenges, Maiwald Patentanwalts GmbH
Status:
Request for examination was made
EP16857896

ANTIMICROBIAL COATINGS

IPC classification:
C07D 233/02, C09D 5/14, B82Y 30/00, B81C 1/00, B82B 1/00, A01N 43/50, A01N 59/16, A01N 25/34
Applicant:
Agency for Science, Technology and Research
Agent:
Martin Huenges, Maiwald Patentanwalts GmbH
Status:
Request for examination was made
EP16857592

HETEROCYCLIC COMPOUND

IPC classification:
C07D 519/00, C07D 513/04, C07D 487/04, A61P 43/00, A61P 25/00, A61P 13/12, A61P 1/16, A61P 1/00, A61K 31/554, A61K 31/553, A61K 31/55, C07D 471/04
Applicant:
Takeda Pharmaceutical Company Limited
Agent:
Martin Huenges, Maiwald Patentanwalts GmbH
Status:
Request for examination was made
EP15906427

METHOD FOR CONSTRUCTING HIGH-RESOLUTION SINGLE CELL HI-C LIBRARY WITH A LOT OF INFORMATION

IPC classification:
C12Q 1/68, C40B 50/06
Agent:
Martin Huenges, Maiwald Patentanwalts GmbH
Status:
Request for examination was made
EP16798612

ANTI-BCMA POLYPEPTIDES AND PROTEINS

IPC classification:
A61K 39/00, C07K 16/28
Agent:
Martin Huenges, Maiwald Patentanwalts GmbH
Status:
Request for examination was made
EP15908522

METHOD FOR BUILDING DNA LIBRARY FOR SEQUENCING

IPC classification:
C12Q 1/68, C40B 40/06, C40B 50/06
Agent:
Martin Huenges, Maiwald Patentanwalts GmbH
Status:
Request for examination was made
EP16869518

METHOD FOR CONSTRUCTING SECOND-GENERATION SEQUENCING LIBRARY FOR DETECTION OF LOW-FREQUENCY MUTATION, AND KIT THEREFOR

IPC classification:
C40B 40/06, C40B 50/06, C12N 15/10
Agent:
Martin Huenges, Maiwald Patentanwalts GmbH
Status:
Request for examination was made
EP16721331

GENE THERAPY FOR COMBINED METHYLMALONIC ACIDEMIA/ACIDURIA AND HYPERHOMOCYSTEINEMIA/HOMOCYSTINURIA, COBALAMIN C TYPE, AND DEFICIENCY OF MMACHC

IPC classification:
C12N 15/67, C07K 14/435, G01N 33/50
Agent:
Martin Huenges, Maiwald Patentanwalts GmbH
Status:
Request for examination was made

Please Sign in to use this feature